Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery

The financing, led by ICONIQ Growth, enables Causaly to accelerate innovation and drive increased adoption of its category-leading AI platform to modernize scientific research.LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Causaly, the leading AI platform for biomedical research, closed $60m in Series B funding led by ICO...

Related Keywords

Sydney ,New South Wales ,Australia ,Tel Aviv ,Israel ,London ,City Of ,United Kingdom ,New York ,United States ,Walker Sands ,Olivier Pomel ,Artur Saudabayev ,Caroline Xie ,Carlos Gonzalez Cadenas ,Yiannis Kiachopoulos ,Alex Gorsky ,Drug Administration ,Johnson ,National Institute Of Environmental Health Sciences ,Novo Nordisk ,Life Sciences ,Visionaries Club ,Index Ventures ,Marathon Venture Capital ,Pentech Ventures ,National Institute ,Environmental Health ,Red Ventures ,San Francisco ,